Fenwick Life Sciences

ID: 1b83136a-2619-30fb-68c4

/

Claimed Record

/

Organization: Fenwick & West LLP

A More Consistent USPTO Approach to Patent Eligibility

Life Sciences Legal Insights · July 17, 2017

Biosimilars: Solicitor General Recommends Granting Certiorari in Amgen v. Sandoz

Life Sciences Legal Insights · December 19, 2016

Will the Supreme Court Review Whether FDA-Mandated Bioequivalence Testing to Maintain Approval Falls Within the § 271(e)(1) Safe Harbor?

Life Sciences Legal Insights · August 15, 2016

Federal Circuit: A Biosimilar Applicant Must Provide Notice of Intent to Market a Biosimilar Product, No Exceptions

Life Sciences Legal Insights · July 20, 2016

Biosimilars: Supreme Court Calls for Solicitor General’s Views in Amgen v. Sandoz

Life Sciences Legal Insights · June 23, 2016

Practice Areas

Health Care and Life Sciences

Jurisdictions